Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine–Glutamate Crosstalk
Взаимодействия с участием глицина и других аминокислотных нейромедиаторов: акцент на опосредованной транспортерами регуляции высвобождения и перекрестном взаимодействии глицина и глутамата
2024-07-08
SCID: 54.1/67wukey2
Discuss with AI
NMDA receptorsglycine neurotransmissionglycine transportersglycine–glutamate crosstalktransporter-mediated regulation
Figures from the paper
Abstract (AI)
Glycine plays a pivotal role in the Central Nervous System (CNS), being a major inhibitory neurotransmitter as well as a co-agonist of Glutamate at excitatory NMDA receptors. Interactions involving Glycine and other neurotransmitters are the subject of different studies. Functional interactions among neurotransmitters include the modulation of release through release-regulating receptors but also through transporter-mediated mechanisms. Many transporter-mediated interactions involve the amino acid transmitters Glycine, Glutamate, and GABA. Different studies published during the last two decades investigated a number of transporter-mediated interactions in depth involving amino acid transmitters at the nerve terminal level in different CNS areas, providing details of mechanisms involved and suggesting pathophysiological significances. Here, this evidence is reviewed also considering additional recent information available in the literature, with a special (but not exclusive) focus on glycinergic neurotransmission and Glycine-Glutamate interactions. Some possible pharmacological implications, although partly speculative, are also discussed. Dysregulations in glycinergic and glutamatergic transmission are involved in relevant CNS pathologies. Pharmacological interventions on glycinergic targets (including receptors and transporters) are under study to develop novel therapies against serious CNS pathological states including pain, schizophrenia, epilepsy, and neurodegenerative diseases. Although with limitations, it is hoped to possibly contribute to a better understanding of the complex interactions between glycine-mediated neurotransmission and other major amino acid transmitters, also in view of the current interest in potential drugs acting on "glycinergic" targets.
Key Findings
1
Amino acid neurotransmitters, particularly glycine, glutamate, and GABA, interact through transporter-mediated mechanisms that regulate transmitter release at nerve terminals.
2
Dysregulation of glycinergic and glutamatergic transmission contributes to CNS disorders including pain, schizophrenia, epilepsy, and neurodegenerative diseases.
3
Glycine serves both as a major inhibitory neurotransmitter and as a co-agonist with glutamate at excitatory NMDA receptors.
4
Glycinergic receptors and transporters are being investigated as pharmacological targets, although therapeutic implications remain partly speculative and subject to limitations.
5
Research over the past two decades has elucidated transporter-mediated glycine–glutamate interactions across different CNS regions and indicated their possible pathophysiological significance.
Research Object
Transporter-mediated interactions among glycine, glutamate, GABA, and other amino acid neurotransmitters at CNS nerve terminals
Research Subject
Regulation of neurotransmitter release and glycine–glutamate crosstalk, including their mechanisms and pharmacological implications
Publication Details
Publication Date
2024-07-08
Journal
Publisher
ISSN
Cited by
27
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest